Sanofi (XTER:SNW) Total Premiums Earned

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:SNW Sanofi SA XTER:SNW
83 GF Score
Price €74.10
GF Value €107.38
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.

XTER:SNW
83GF Score
Sanofi SA XTER:SNW
Total Premiums Earned is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (XTER:SNW) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €74.10 is trading 31% below its estimated GF Value™ of €107.38. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for XTER:SNW:

  • Total Premiums Earned:
  • GF Value™: €107.38 vs. price of €74.10 (31% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the XTER:SNW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
83GF Score

Get the complete analysis for XTER:SNW

Total Premiums Earned is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.10
Price
€107.38
GF Value